Valproate-induced pure red cell aplasia and megakaryocyte dysplasia
Right atrial myeloid sarcoma causing superior vena cava syndrome
Anti-CD20 monoclonal antibody therapy in multiple myeloma
Rituximab in the treatment of autoimmune haematological disorders
Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation
Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders
Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma
Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia
Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease
Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma
Thalidomide in advanced mastocytosis
Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia
Sarcoidosis and haematological malignancies
ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions
Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma
Emergency warfarin reversal with prothrombin complex concentrates
ACE I/D polymorphism and recurrent first trimester pregnancy loss
Detection of WT1-specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission
Corrigendum